During the past two years political committees supporting Republican Attorney General Russell Coleman have quietly raised $1 ...

Nicotine, regardless of the delivery system, is a “potent cardiovascular toxin,” states a recent report, calling for urgent ...

How the tobacco industry rebranded a brutally addictive drug from deadly to desirable—and what it means for our health.

Altria relies on cigarettes as vapes face bans, flavors grow and on! competes with ZYN, with low multiple and 7.5% dividend ...

Truth Initiative aims to encourage and inspire anyone who relapsed after quitting nicotine as a New Year's resolution by bringing back "You Got This Day," a national moment dedicated to recommitting ...

Altria has an attractive 7.4% dividend yield backed by a growing dividend, but there is more for investors to consider.

On the surface, the tobacco giant looks too tempting to ignore. However, some tantalizing metrics may belie reasons for long-term concern. Investors must examine Altria’s dividend sustainability. 10 ...

After being heavily implicated in the teen vaping crisis — including years of legal battles and agreeing to pay out $1.7 billion over claims of misleading advertising — many assumed Juul Labs was a ...

Juul has officially been approved by the FDA to sell menthol and tobacco e-cigarettes. Juul joins three other FDA approved brands. Efforts are being made across the U.S. and in Illinois to cut down on ...

The U.S. Food and Drug Administration made the controversial decision to authorize the sale of Juul e-cigarettes, including menthol-flavored varieties, on July 17, stunning the public health world.

Editor’s note: “Behind the News” is the product of Sun staff assisted by the Sun’s AI lab, which includes a variety of tools such as Anthropic’s Claude, Perplexity AI, Google Gemini and ChatGPT. The ...